Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.3 (
RNase III
)
1,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An isogenic pair of Escherichia coli strains, one carrying an rnc+ and the other an rnc- allele (a mutation which reduces the level of
ribonuclease III
), was compared. The rnc- strain fails to grow at very elevated temperatures (for
E. coli)
while the rnc+ strain does grow exponentially. Assaying the residual
RNase III
like activity in extracts of the rnc- strain at different pHs and at different temperatures suggested that this residual
RNase III
like activity is not due to
RNase III
. This raised the possibility that the rnc- strain is devoid of any
RNase III
activity in the cell. Comparing the decay of newly synthesized RNA and functional decay of beta-galactosidase mRNA in such strains revealed that in both strains these parameters proceed in similar rates, which suggests that
RNase III
is not involved in the metabolism of mRNA. During carbon starvation preexisting total RNA, as well as 23S and 16S rRNA, decay faster in the rnc- strain, thus eliminating the possibility that
RNase III
is the endoribonuclease which initiates the decay of rRNA during starvation (Kaplan and Apirion, 1975a).
...
PMID:Consequences of losing ribonuclease III on the Escherichia coli cell. 77 91